These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21342755)

  • 1. Risks and benefits of copper in light of new insights of copper homeostasis.
    de Romaña DL; Olivares M; Uauy R; Araya M
    J Trace Elem Med Biol; 2011 Jan; 25(1):3-13. PubMed ID: 21342755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essentiality and toxicity in copper health risk assessment: overview, update and regulatory considerations.
    Stern BR
    J Toxicol Environ Health A; 2010; 73(2):114-27. PubMed ID: 20077283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of copper, molybdenum, selenium, and zinc in nutrition and health.
    Chan S; Gerson B; Subramaniam S
    Clin Lab Med; 1998 Dec; 18(4):673-85. PubMed ID: 9891606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hohenheim consensus workshop: copper.
    Schümann K; Classen HG; Dieter HH; König J; Multhaup G; Rükgauer M; Summer KH; Bernhardt J; Biesalski HK
    Eur J Clin Nutr; 2002 Jun; 56(6):469-83. PubMed ID: 12032645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of essentiality on risk assessment.
    Becking GC
    Biol Trace Elem Res; 1998; 66(1-3):423-38. PubMed ID: 10050935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper and human health: biochemistry, genetics, and strategies for modeling dose-response relationships.
    Stern BR; Solioz M; Krewski D; Aggett P; Aw TC; Baker S; Crump K; Dourson M; Haber L; Hertzberg R; Keen C; Meek B; Rudenko L; Schoeny R; Slob W; Starr T
    J Toxicol Environ Health B Crit Rev; 2007; 10(3):157-222. PubMed ID: 17454552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An exposure-response curve for copper excess and deficiency.
    Chambers A; Krewski D; Birkett N; Plunkett L; Hertzberg R; Danzeisen R; Aggett PJ; Starr TB; Baker S; Dourson M; Jones P; Keen CL; Meek B; Schoeny R; Slob W
    J Toxicol Environ Health B Crit Rev; 2010 Oct; 13(7-8):546-78. PubMed ID: 21170809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper nutriture, bioavailability, and the influence of dietary factors.
    Turnlund JR
    J Am Diet Assoc; 1988 Mar; 88(3):303-8. PubMed ID: 3279098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity due to excess and deficiency.
    Aggett PJ
    J Toxicol Environ Health A; 2010; 73(2):175-80. PubMed ID: 20077288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How reliable and robust are current biomarkers for copper status?
    Danzeisen R; Araya M; Harrison B; Keen C; Solioz M; Thiele D; McArdle HJ
    Br J Nutr; 2007 Oct; 98(4):676-83. PubMed ID: 17666147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of diamine oxidase and other plasma copper biomarkers to various dietary copper intakes in the rat and evaluation of copper absorption with a stable isotope.
    Feillet-Coudray C; Coudray C; Bayle D; Rock E; Rayssiguier Y; Mazur A
    Br J Nutr; 2000 May; 83(5):561-8. PubMed ID: 10953681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper in diseases and treatments, and copper-based anticancer strategies.
    Tisato F; Marzano C; Porchia M; Pellei M; Santini C
    Med Res Rev; 2010 Jul; 30(4):708-49. PubMed ID: 19626597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technical note: copper chaperone for copper, zinc superoxide dismutase: a potential biomarker for copper status in cattle.
    Hepburn JJ; Arthington JD; Hansen SL; Spears JW; Knutson MD
    J Anim Sci; 2009 Dec; 87(12):4161-6. PubMed ID: 19717775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in the regulation of intestinal copper absorption.
    van den Berghe PV; Klomp LW
    Nutr Rev; 2009 Nov; 67(11):658-72. PubMed ID: 19906252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune system as a physiological indicator of marginal copper status?
    Bonham M; O'Connor JM; Hannigan BM; Strain JJ
    Br J Nutr; 2002 May; 87(5):393-403. PubMed ID: 12010579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a copper database for exposure-response analysis.
    Krewski D; Chambers A; Stern BR; Aggett PJ; Plunkett L; Rudenko L
    J Toxicol Environ Health A; 2010; 73(2):208-16. PubMed ID: 20077291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of copper status: a brief update.
    Harvey LJ; McArdle HJ
    Br J Nutr; 2008 Jun; 99 Suppl 3():S10-3. PubMed ID: 18598583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wilson disease: not just a copper disorder. Analysis of a Wilson disease model demonstrates the link between copper and lipid metabolism.
    Huster D; Lutsenko S
    Mol Biosyst; 2007 Dec; 3(12):816-24. PubMed ID: 18000558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of categorical regression in modeling copper exposure-response relationships.
    Krewski D; Chambers A; Birkett N
    J Toxicol Environ Health A; 2010; 73(2):187-207. PubMed ID: 20077290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.